세계의 색소침착증 치료 시장 보고서(2025년)

Hyperpigmentation disorder treatment involves various methods aimed at reducing the appearance of dark spots or patches on the skin caused by excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid are commonly used to lighten the skin.

Treatment types in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy, and other treatments. Cosmeceuticals are cosmetics with active ingredients that may have therapeutic effects on the skin. They are utilized to treat various conditions, including melasma, post-inflammatory hyperpigmentation, solar lentigines, and other indications. These treatments are administered by various end-users, including hospitals, esthetic clinics, dermatology centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The hyperpigmentation disorder treatment market research report is one of a series of new reports from The Business Research Company that provides hyperpigmentation disorder treatment optical components market statistics, including hyperpigmentation disorder treatment optical components industry global market size, regional shares, competitors with a hyperpigmentation disorder treatment optical components market share, detailed hyperpigmentation disorder treatment optical components market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment optical components industry. This hyperpigmentation disorder treatment optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $5.73 billion in 2024 to $6.12 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to clinical trials and research, advances in chemical peels, cultural shift towards skincare, emphasis on non-invasive options, demand for natural products.

The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $8.56 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to focus on non-invasive treatments, enhanced skincare awareness, telemedicine and virtual consultations, regulatory support and approvals, personalized treatment options. Major trends in the forecast period include innovative topical formulations, advancements in laser technologies, focus on combination therapies, personalized treatment approaches, rising demand for natural products.

The forecast of 8.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of topical tranexamic acid and laser therapy devices sourced from South Korea and Italy, thereby reducing access to cosmetic and medical dermatology treatments and elevating out-of-pocket costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The expected increase in the prevalence of pigmentation disorders is anticipated to fuel the growth of the hyperpigmentation disorders treatment market. Pigmentation disorders encompass various conditions affecting the coloration of the skin, hair, and eye iris, typically resulting from issues with melanin, the pigment produced by melanocytes. Treatment options for hyperpigmentation disorders vary based on the underlying cause and severity, with mild cases often managed through over-the-counter topical creams containing ingredients such as azelaic acid, cysteamine cream, vitamin C, and hydroquinone, known for their skin-lightening properties. For example, a report from the Centers for Disease Control (CDC) in March 2023 highlighted an increase in Candida auris cases in the US from 476 in 2019 to 1,471 in 2021. Additionally, the National Psoriasis Foundation reported in December 2022 that psoriasis affects 125 million people globally, representing 2 to 3 percent of the overall population. The rise in pigmentation disorders' prevalence is expected to drive the growth of the hyperpigmentation disorders treatment market.

The growth of the hyperpigmentation disorder treatment market is further propelled by increasing cosmetic concerns. Cosmetic concerns refer to worries or considerations related to one's physical appearance, beauty, or aesthetics. The rising focus on cosmetic concerns encourages individuals to seek hyperpigmentation disorder treatments, fostering innovation in the cosmetic and dermatological industries and enhancing the overall patient experience. Reports from the International Society of Aesthetic Plastic Surgery (ISAPS) in September 2023 revealed that plastic surgeons are expected to perform over 14.9 million surgical and 18.8 million non-surgical operations in 2022, reflecting an overall increase of 11.2%. The heightened emphasis on cosmetic concerns is a significant driver behind the growth of the hyperpigmentation disorder treatment market.

Major companies in the hyperpigmentation disorders treatment market are concentrating on developing glycolic acid solutions to enhance their market position and secure a competitive edge. Glycolic acid solutions are skincare formulations that contain glycolic acid, an alpha hydroxy acid (AHA) recognized for its exfoliating benefits, which help to improve skin texture, brightness, and overall appearance by encouraging cell turnover. For example, in February 2024, L'Oreal SA, a personal care company based in France, introduced the Glycolic Bright Dark Circle Eye Serum, designed to address dark circles and dullness around the eyes. This innovative serum utilizes glycolic acid for its exfoliating effects, promoting brighter skin and improved texture. The formulation likely also incorporates hydrating ingredients to nourish the sensitive eye area.

Major players in the hyperpigmentation disorder treatment market are strategically launching innovative products to meet the growing demand for effective and safe hyperpigmentation treatment. A noteworthy example is the Cyspera Intensive System, unveiled by Cyspera (Scientis SA), a Switzerland-based dermatology company. This revolutionary three-step hyperpigmentation treatment is meticulously designed to target persistent brown patches and dark spots. The system features a proprietary Cysteamine Isobionic-Amide Complex, a patented melanosomal transfer inhibitor within the vitamin B3 family. This complex collaborates synergistically with cysteamine to deliver three powerful effects. In essence, the Cyspera Intensive System emerges as a promising new option for hyperpigmentation treatment, ensuring safety and efficacy for all skin types without harsh chemicals.

In July 2023, Reveal Lasers LLC, a US-based manufacturer of aesthetic lasers and RF devices, merged with NEOconcepts LLC. This merger allows Reveal Lasers to acquire the AgeJET Advanced Plasma Skin Therapy Device, facilitating its entry into a new treatment area and strengthening AgeJET's presence in the US market. NEOconcepts LLC specializes in providing aesthetic treatment products and devices.

Major companies operating in the hyperpigmentation disorder treatment market include Vivier Pharma, Obagi Cosmeceuticals LLC, RXi Pharmaceuticals Corporation, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Bayer AG, Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, Episciences Inc., La Roche-Posay, L'Oreal S.A., Pierre Fabre Laboratories, Alvogen Inc., Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries, SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estee Lauder Companies Inc.

North America was the largest region in the hyperpigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in the hyperpigmentation disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hyperpigmentation disorder treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hyperpigmentation Disorder Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hyperpigmentation disorder treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hyperpigmentation disorder treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hyperpigmentation disorder treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Cosmeceuticals; Laser Therapy; Chemical Peels; Microdermabrasion; Phototherapy; Other Treatments
• 2) By Disease Indication: Melasma; Post-Inflammatory Hyperpigmentation; Solar Lentigines; Other Disease Indications
• 3) By End-Users: Hospitals; Esthetic Clinics And Dermatology Centers; Other End-Users
• Subsegments:
• 1) By Cosmeceuticals: Topical Creams and Gels; Serums and Lotions; Sunscreens; Laser Therapy
• 2) By Laser Therapy: Fractional Laser Resurfacing; Intense Pulsed Light (IPL) Therapy
• 3) By Chemical Peels: Superficial Peels; Medium Depth Peels; Deep Peels
• 4) By Microdermabrasion: Crystal Microdermabrasion; Diamond Microdermabrasion
• 5) By Phototherapy: Blue Light Therapy; Red Light Therapy
• 6) By Other Treatments: Cryotherapy; Dermal Fillers; Microneedling
• Companies Mentioned: Vivier Pharma; Obagi Cosmeceuticals LLC; RXi Pharmaceuticals Corporation; EpiPharm AG; Laboratories Pierre Fabre; SkinCeuticals; Galderma S.A.; Allergan PLC.; Bayer AG; Lumenis Be Ltd.; Aerolase Corporation; Candela Corporation; Cynosure; PCA Skin; Episciences Inc.; La Roche-Posay; L'Oreal S.A.; Pierre Fabre Laboratories; Alvogen Inc.; Clinuvel Pharmaceuticals Ltd.; Clarify Medical Inc.; Incyte Corporation; Dr. Reddy's Laboratories Ltd.; Glenmark Pharmaceuticals Ltd.; Teva Pharmaceutical Industries; SkinMedica Inc.; Neutrogena Corporation; Paula's Choice Inc.; ZO Skin Health Inc.; Estee Lauder Companies Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hyperpigmentation Disorder Treatment Market Characteristics

3. Hyperpigmentation Disorder Treatment Market Trends And Strategies

4. Hyperpigmentation Disorder Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hyperpigmentation Disorder Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hyperpigmentation Disorder Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hyperpigmentation Disorder Treatment Market Growth Rate Analysis
• 5.4. Global Hyperpigmentation Disorder Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hyperpigmentation Disorder Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hyperpigmentation Disorder Treatment Total Addressable Market (TAM)

6. Hyperpigmentation Disorder Treatment Market Segmentation

• 6.1. Global Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cosmeceuticals
• Laser Therapy
• Chemical Peels
• Microdermabrasion
• Phototherapy
• Other Treatments
• 6.2. Global Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Melasma
• Post-Inflammatory Hyperpigmentation
• Solar Lentigines
• Other Disease Indications
• 6.3. Global Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Esthetic Clinics And Dermatology Centers
• Other End-Users
• 6.4. Global Hyperpigmentation Disorder Treatment Market, Sub-Segmentation Of Cosmeceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Creams and Gels
• Serums and Lotions
• Sunscreens
• Laser Therapy
• 6.5. Global Hyperpigmentation Disorder Treatment Market, Sub-Segmentation Of Laser Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fractional Laser Resurfacing
• Intense Pulsed Light (IPL) Therapy
• 6.6. Global Hyperpigmentation Disorder Treatment Market, Sub-Segmentation Of Chemical Peels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Superficial Peels
• Medium Depth Peels
• Deep Peels
• 6.7. Global Hyperpigmentation Disorder Treatment Market, Sub-Segmentation Of Microdermabrasion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Crystal Microdermabrasion
• Diamond Microdermabrasion
• 6.8. Global Hyperpigmentation Disorder Treatment Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blue Light Therapy
• Red Light Therapy
• 6.9. Global Hyperpigmentation Disorder Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryotherapy
• Dermal Fillers
• Microneedling

7. Hyperpigmentation Disorder Treatment Market Regional And Country Analysis

• 7.1. Global Hyperpigmentation Disorder Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hyperpigmentation Disorder Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hyperpigmentation Disorder Treatment Market

• 8.1. Asia-Pacific Hyperpigmentation Disorder Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hyperpigmentation Disorder Treatment Market

• 9.1. China Hyperpigmentation Disorder Treatment Market Overview
• 9.2. China Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hyperpigmentation Disorder Treatment Market

• 10.1. India Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hyperpigmentation Disorder Treatment Market

• 11.1. Japan Hyperpigmentation Disorder Treatment Market Overview
• 11.2. Japan Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hyperpigmentation Disorder Treatment Market

• 12.1. Australia Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hyperpigmentation Disorder Treatment Market

• 13.1. Indonesia Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hyperpigmentation Disorder Treatment Market

• 14.1. South Korea Hyperpigmentation Disorder Treatment Market Overview
• 14.2. South Korea Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hyperpigmentation Disorder Treatment Market

• 15.1. Western Europe Hyperpigmentation Disorder Treatment Market Overview
• 15.2. Western Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hyperpigmentation Disorder Treatment Market

• 16.1. UK Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hyperpigmentation Disorder Treatment Market

• 17.1. Germany Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hyperpigmentation Disorder Treatment Market

• 18.1. France Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hyperpigmentation Disorder Treatment Market

• 19.1. Italy Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hyperpigmentation Disorder Treatment Market

• 20.1. Spain Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hyperpigmentation Disorder Treatment Market

• 21.1. Eastern Europe Hyperpigmentation Disorder Treatment Market Overview
• 21.2. Eastern Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hyperpigmentation Disorder Treatment Market

• 22.1. Russia Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hyperpigmentation Disorder Treatment Market

• 23.1. North America Hyperpigmentation Disorder Treatment Market Overview
• 23.2. North America Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hyperpigmentation Disorder Treatment Market

• 24.1. USA Hyperpigmentation Disorder Treatment Market Overview
• 24.2. USA Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hyperpigmentation Disorder Treatment Market

• 25.1. Canada Hyperpigmentation Disorder Treatment Market Overview
• 25.2. Canada Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hyperpigmentation Disorder Treatment Market

• 26.1. South America Hyperpigmentation Disorder Treatment Market Overview
• 26.2. South America Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hyperpigmentation Disorder Treatment Market

• 27.1. Brazil Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hyperpigmentation Disorder Treatment Market

• 28.1. Middle East Hyperpigmentation Disorder Treatment Market Overview
• 28.2. Middle East Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hyperpigmentation Disorder Treatment Market

• 29.1. Africa Hyperpigmentation Disorder Treatment Market Overview
• 29.2. Africa Hyperpigmentation Disorder Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hyperpigmentation Disorder Treatment Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hyperpigmentation Disorder Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hyperpigmentation Disorder Treatment Market Competitive Landscape And Company Profiles

• 30.1. Hyperpigmentation Disorder Treatment Market Competitive Landscape
• 30.2. Hyperpigmentation Disorder Treatment Market Company Profiles
  • 30.2.1. Vivier Pharma Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Obagi Cosmeceuticals LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. RXi Pharmaceuticals Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. EpiPharm AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Laboratories Pierre Fabre Overview, Products and Services, Strategy and Financial Analysis

31. Hyperpigmentation Disorder Treatment Market Other Major And Innovative Companies

• 31.1. SkinCeuticals
• 31.2. Galderma S.A.
• 31.3. Allergan PLC.
• 31.4. Bayer AG
• 31.5. Lumenis Be Ltd.
• 31.6. Aerolase Corporation
• 31.7. Candela Corporation
• 31.8. Cynosure
• 31.9. PCA Skin
• 31.10. Episciences Inc.
• 31.11. La Roche-Posay
• 31.12. L'Oreal S.A.
• 31.13. Pierre Fabre Laboratories
• 31.14. Alvogen Inc.
• 31.15. Clinuvel Pharmaceuticals Ltd.

32. Global Hyperpigmentation Disorder Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hyperpigmentation Disorder Treatment Market

34. Recent Developments In The Hyperpigmentation Disorder Treatment Market

35. Hyperpigmentation Disorder Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Hyperpigmentation Disorder Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hyperpigmentation Disorder Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hyperpigmentation Disorder Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer